These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27074937)

  • 41. External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection.
    Gacci M; Schiavina R; Lanciotti M; Masieri L; Serni S; Vagnoni V; Abdollah F; Carini M; Martorana G; Montorsi F
    Urol Int; 2013; 90(3):277-82. PubMed ID: 23296120
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).
    Dwivedi DK; Kumar R; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
    NMR Biomed; 2016 Mar; 29(3):232-8. PubMed ID: 26730884
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of quantitative magnetic resonance imaging parameters with histological findings from MRI/ultrasound fusion prostate biopsy.
    Dianat SS; Carter HB; Schaeffer EM; Hamper UM; Epstein JI; Macura KJ
    Can J Urol; 2015 Oct; 22(5):7965-72. PubMed ID: 26432966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extended prostate biopsy scheme improves reliability of Gleason grading: implications for radiotherapy patients.
    King CR; McNeal JE; Gill H; Presti JC
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):386-91. PubMed ID: 15145152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients.
    Leyh-Bannurah SR; Dell'Oglio P; Tian Z; Schiffmann J; Shariat SF; Suardi N; Francesco M; Alberto B; Heinzer H; Huland H; Graefen M; Budäus L; Karakiewicz PI
    World J Urol; 2017 Feb; 35(2):189-197. PubMed ID: 27289238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy.
    Arsov C; Becker N; Rabenalt R; Hiester A; Quentin M; Dietzel F; Antoch G; Gabbert HE; Albers P; Schimmöller L
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):2061-8. PubMed ID: 26013424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy.
    Patel U; Dasgupta P; Challacombe B; Cahill D; Brown C; Patel R; Kirby R
    BJU Int; 2017 Jan; 119(1):82-90. PubMed ID: 27153933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does suspicion of prostate cancer on integrated T2 and diffusion-weighted MRI predict more adverse pathology on radical prostatectomy?
    Borofsky MS; Rosenkrantz AB; Abraham N; Jain R; Taneja SS
    Urology; 2013 Jun; 81(6):1279-83. PubMed ID: 23394882
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percentages of positive cores, cancer length and Gleason grade 4/5 cancer in systematic sextant biopsy are all predictive of adverse pathology and biochemical failure after radical prostatectomy.
    Suekane S; Noguchi M; Nakashima O; Yamada S; Kojiro M; Matsuoka K
    Int J Urol; 2007 Aug; 14(8):713-8. PubMed ID: 17681061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study.
    Thompson JE; Moses D; Shnier R; Brenner P; Delprado W; Ponsky L; Pulbrook M; Böhm M; Haynes AM; Hayen A; Stricker PD
    J Urol; 2014 Jul; 192(1):67-74. PubMed ID: 24518762
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathologic outcomes for low-risk prostate cancer after delayed radical prostatectomy in the United States.
    Weiner AB; Patel SG; Eggener SE
    Urol Oncol; 2015 Apr; 33(4):164.e11-7. PubMed ID: 25624093
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anterior Prostate Cancer: Diagnostic Performance of T2-Weighted MRI and an Apparent Diffusion Coefficient Map.
    Shinmoto H; Tamura C; Soga S; Okamura T; Horiguchi A; Asano T; Kaji T
    AJR Am J Roentgenol; 2015 Aug; 205(2):W185-92. PubMed ID: 26204306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancer.
    Porcaro AB; Gallina S; Bianchi A; Cerrato C; Tafuri A; Rizzetto R; Amigoni N; Orlando R; Serafin E; Gozzo A; Migliorini F; Antoniolli SZ; Lacola V; De Marco V; Brunelli M; Cerruto MA; Siracusano S; Antonelli A
    Int Urol Nephrol; 2021 Dec; 53(12):2505-2515. PubMed ID: 34677784
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason Score.
    Porpiglia F; DE Luca S; Passera R; Manfredi M; Mele F; Bollito E; DE Pascale A; Cossu M; Aimar R; Veltri A
    Anticancer Res; 2016 Sep; 36(9):4833-9. PubMed ID: 27630337
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Triage of low-risk prostate cancer patients with PSA levels 10 ng/ml or less: comparison of apparent diffusion coefficient value and transrectal ultrasound-guided target biopsy.
    Itatani R; Namimoto T; Kajihara H; Katahira K; Kitani K; Hamada Y; Yamashita Y
    AJR Am J Roentgenol; 2014 May; 202(5):1051-7. PubMed ID: 24758659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Likert score 3 prostate lesions: Association between whole-lesion ADC metrics and pathologic findings at MRI/ultrasound fusion targeted biopsy.
    Rosenkrantz AB; Meng X; Ream JM; Babb JS; Deng FM; Rusinek H; Huang WC; Lepor H; Taneja SS
    J Magn Reson Imaging; 2016 Feb; 43(2):325-32. PubMed ID: 26131965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diffuse Peripheral Zone T2 Hypointensity: When to Worry About Prostate Cancer.
    Navot B; Ahmed FS; Shaish H
    J Comput Assist Tomogr; 2019; 43(4):641-644. PubMed ID: 31162234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison between Gleason score and apparent diffusion coefficient obtained from diffusion-weighted imaging of prostate cancer patients.
    Caivano R; Rabasco P; Lotumolo A; Cirillo P; D'Antuono F; Zandolino A; Villonio A; Macarini L; Salvatore M; Cammarota A
    Cancer Invest; 2013 Nov; 31(9):625-9. PubMed ID: 24138289
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The percentage of prostate needle biopsy cores with carcinoma from the more involved side of the biopsy as a predictor of prostate specific antigen recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
    Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC
    Cancer; 2003 Dec; 98(11):2344-50. PubMed ID: 14635068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.